Xortx Therapeutics Inc (XRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 823 | 686 | 716 | 890 | 964 |
| Operating Income | -823 | -690 | -716 | -890 | -964 |
| Other Income | 15 | 100 | 67 | 172 | 265 |
| Pre-tax Income | -809 | -591 | -650 | -718 | -699 |
| Net Income Continuous | -809 | -591 | -650 | -718 | -699 |
| Net Income | $-809 | $-591 | $-650 | $-718 | $-699 |
| EPS Basic Total Ops | -0.58 | -0.27 | -0.65 | -0.95 | -0.93 |
| EPS Basic Continuous Ops | -0.58 | -0.25 | -0.67 | -0.95 | -0.93 |
| EPS Diluted Total Ops | -0.58 | -0.27 | -0.65 | -0.95 | -0.93 |
| EPS Diluted Continuous Ops | -0.58 | -0.25 | -0.67 | -0.95 | -0.93 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.45 | -0.65 | -0.95 | -0.95 |
| EBITDA(a) | $-798 | $-657 | $-687 | $-862 | $-938 |